Login / Signup
Knockdown of GNL3 inhibits LUAD cell growth by regulating Wnt-β-catenin pathway.
Guihong Dai
Yuejun Sun
Published in:
Allergologia et immunopathologia (2024)
GNL3 is key in the progression of LUAD by metiating Wnt/β-catenin axis. Targeting GNL3 may represent a novel therapeutic method for LUAD treatment.
Keyphrases
</>
cell proliferation
stem cells
epithelial mesenchymal transition
cancer therapy
replacement therapy